Covid-19: India records 12,923 fresh cases, 108 more fatalities recorded

India's COVID-19 tally has climbed to 1,08,71,294 with 12,923 fresh cases reported in a day

coronavirus vaccine
Surat district collector Dr.Dhaval Patel takes the COVISHIELD vaccine and aware people of the COVID-19 vaccination, at Simmer hospital in Surat on Sunday.
Press Trust of India New Delhi
2 min read Last Updated : Feb 11 2021 | 10:26 AM IST

India's COVID-19 tally has climbed to 1,08,71,294 with 12,923 fresh cases reported in a day, while the number of recoveries has surged to 1,05,73,372, the health ministry said on Thursday.

The death toll in the country due to the viral disease has gone up to 1,55,360 with 108 more people succumbing to it, according to the ministry's data updated at 8 am.

The number of people who have recuperated from the disease has surged to 1,05,73,372, which translates to a national COVID-19 recovery rate of 97.26 per cent, while the case fatality rate stands at 1.43per cent.

The country currently has 1,42,562 active COVID-19 cases, which account for only 1.31 per cent of its total caseload, the data stated.

India's COVID-19 tally had crossed the 20-lakh mark on August 7 last year, the 30-lakh mark on August 23, the 40-lakh mark on September 5 and the 50-lakh mark on September 16.

It went past 60 lakh on September 28,70 lakh on October 11, 80 lakh on October 29, 90 lakh on November 20 and the one-crore mark on December 19.

According to the Indian Council of Medical Research (ICMR), 20,40,23,840 samples have so far been tested in the country for COVID-19, including 6,99,185 on Wednesday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Feb 11 2021 | 10:18 AM IST

Next Story